We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

CAR T-cell Therapy: Reprogramming the Immune System To Treat Cancer

Video   Oct 04, 2019 | Taken from TEDx Talks, YouTube

 

At the Malaghan Institute for Biomedical Reserach, researchers are developing third generation CAR-T immunotherapy treatments which aim to be more effective with less side effects than previous therapies.

Using patients own modified T-cells, CAR-T therapy has the ability to vanquish cancer cells, vastly improving outcomes of once life threatening diseases.

This year, 2019, Rob hopes to begin clinical trials for CAR-T therapy in New Zealand through the collaboration of scientists from the Malaghan Institute and international researchers. He is optimistic that this next generation treatment will present a new paradigm for treatment of lymphomas and possibly for other cancers in the future.

Dr Robert Weinkove is Clinical Director of the Malaghan Institute, a biomedical research institute in Wellington, New Zealand. After studying medicine at the University of Cambridge and Kings College London, Rob trained in Hematology in London and Germany before moving to New Zealand in 2008 and gaining a doctorate with the University of Otago.

Rob is a key member of the Cancer Immunotherapy Programme to develop and manufacture ‘chimeric antigen receptor’ (CAR) T-cells for treatment of lymphoma and other blood cancers. He also holds a joint role as a  Hematologist at Wellington Blood & Cancer Centre.

 
More Information
 
 
Advertisement
 

Recommended Videos

Unlocking the Protein Structure of Coronavirus

Video

The novel coronavirus sweeping the globe packs 27 proteins, each adopting a unique, often incredibly complex 3D structure. Each protein is part of the molecular toolkit that the virus uses to infect, replicate, and spread. Understanding the proteins' structures provides a blueprint for drug designs.

WATCH NOW

Testimonial: Use of Rotavapors for Drug Discovery and Formulation in Academic Research

Video

Dr. Fabiana Quaglia, Associate Professor of Pharmaceutical Technology at the Faculty of Pharmacy–University of Napoli Federico II, Italy discusses how reliability and smart features of the rotary evaporator, Rotavapor® R-300, let her easily evaporate solvents in particle production for cancer and cystic fibrosis drug development and formulation.

WATCH NOW

Whole Genome Sequencing for Infectious Disease Outbreaks

Video

This video describes how whole genome sequencing is used to track pathogens as they spread from person to person on the path to a foodborne or infectious disease outbreak.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE